Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03796026 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea
A Phase 1 study, sponsored by Janssen Research & Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT03796026 is a Phase 1 study that has completed, run by Janssen Research & Development. The registered enrollment target is 34 participants.
The verdict
NCT03796026, a Phase 1 study, has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of multiple doses of seltorexant compared with placebo on respiration during sleep in adult participants with mild to moderate obstructive sleep apnea.
Interventions
- DRUG Placebo
- DRUG Seltorexant 40 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2019-06-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03796026
The ClinicalTrials.gov registry entry for NCT03796026 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03796026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03796026 about?
NCT03796026 is a clinical study titled "A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea". The purpose of this study is to evaluate the effect of multiple doses of seltorexant compared with placebo on respiration during sleep in adult participants with mild to moderate obstructive sleep apnea.
What is the current status of trial NCT03796026?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2019-01-04. Estimated completion is 2019-06-14.
What interventions are being tested in trial NCT03796026?
The interventions under investigation include: Placebo (DRUG), Seltorexant 40 mg (DRUG).
Who is sponsoring clinical trial NCT03796026?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.